expenses was 1,719 MTHB, increased by 546 MTHB or 47% from 2016. This increment was mainly from the loss on written-off and disposal of plant and equipments and intangible assets of Solvay Biochemicals
. Analysis of financial status as at 30 September 2020 (Unit: Million Baht) Assets 30 Sep. 2020 % 30 Sep. 2019 % Trade and other receivables 459.99 22.49% 315.22 19% Inventories 140.18 6.85% 116.98 7% Lease
transactions to cash, deferred income tax assets, intangible assets and Other non-current assets (Unit: Million Baht) Liabilities 30 Jun. 2021 % 31 Dec. 2020 % Bank overdrafts and short-term loan 190.00 18
-current assets (Unit: Million Baht) Liabilities 30 Sep. 2021 % 31 Dec. 2020 % Bank overdrafts and short-term loan 200.73 19% 143.00 13% Trade and other payables 345.42 33% 320.84 30% Liabilities under
income tax assets, intangible assets and Other non-current assets (Unit: Million Baht) Liabilities 30 Jun. 2022 % 31 Dec. 2021 % Bank overdrafts and short-term loan 246.00 25% 220.00 23% Trade and other
as at 30 June 2020 (Unit: Million Baht) Assets 30 Jun. 2020 % 31 Dec. 2019 % Trade and other receivables 408.72 20% 315.22 19% Inventories 150.97 7% 116.98 7% Lease receivable 88.03 5% - - Investment
liquidity and to reduce the financial burden. The selling value is 40.48 % when compares to total assets from company consolidated statements. (Market Value 70,370,000.00 x 100 divided by total assets as at
Subsidiaries) (1) Total Assets Company’s total assets as of June 30, 2019 was 1,582.7 million baht, decreased 68.3 million baht or 4.1 percent compared to the total assets as of December 31, 2018. (1.1) Current
005/2017 24 November 2017 Subject: Informing on the acquisition of assets of ZIGA Innovation Public Company Limited Attention: The President The Stock Exchange of Thailand Attachment: Disclosure of